NFKB1 and inflammatory bowel disease: Interestingly, PPAR-α and PPAR-γ have been associated with ROS detoxification and cholesterol biosynthesis, while specifically PPAR-γ is associated with TCA cycle and NF-κB signaling inhibition, whose gene expression is decreased in IBD, affecting these processes (73, 101).